🔴 Marker Therapeutics is trading 6.08% down today amid broader pressure from oil and inflation concerns

Marker Therapeutics is trading at $1.08, down 6.08%, with no confirmed company-specific explanation for the decline.

• No September 28 company-specific announcement was identified; the latest company release was September 22.
• Renewed U.S.-Iran tensions pushed oil higher and reignited inflation concerns.
• Reuters reported U.S. stock-index futures fell as yields rose, a macro backdrop that may weigh on shares; available reports do not directly attribute Marker Therapeutics’ decline to it.